Menu
GeneBe

CAVIN1

caveolae associated protein 1, the group of Cavins

Basic information

Region (hg38): 17:42402448-42423256

Previous symbols: [ "PTRF" ]

Links

ENSG00000177469NCBI:284119OMIM:603198HGNC:9688Uniprot:Q6NZI2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Berardinelli-Seip congenital lipodystrophy (Supportive), mode of inheritance: AR
  • congenital generalized lipodystrophy type 4 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Lipodystrophy, congenital generalized, type 4ARCardiovascularAmong other manifestations, individuals may demonstrate cardiac arrhythmias, and appropriate surveillance and management may be beneficialCardiovascular; Endocrine; Gastrointestinal; Musculoskeletal12116229; 18698612; 19726876; 20300641; 20684003

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CAVIN1 gene.

  • Congenital generalized lipodystrophy type 4 (73 variants)
  • not provided (37 variants)
  • Monogenic diabetes (6 variants)
  • Inborn genetic diseases (6 variants)
  • not specified (5 variants)
  • CAVIN1-related condition (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAVIN1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
6
clinvar
2
clinvar
14
missense
25
clinvar
25
nonsense
2
clinvar
2
start loss
0
frameshift
1
clinvar
1
clinvar
2
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
22
clinvar
17
clinvar
19
clinvar
58
Total 1 3 55 23 21

Variants in CAVIN1

This is a list of pathogenic ClinVar variants found in the CAVIN1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-42402476-C-T Congenital generalized lipodystrophy type 4 Likely benign (Jan 13, 2018)323253
17-42402572-C-A Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 12, 2018)889013
17-42402639-A-G Congenital generalized lipodystrophy type 4 Likely benign (Jan 13, 2018)323254
17-42402697-T-G Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 13, 2018)323255
17-42402732-A-G Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 12, 2018)889709
17-42402775-G-A Congenital generalized lipodystrophy type 4 Likely benign (Jan 13, 2018)889710
17-42402792-G-C Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 13, 2018)889711
17-42402831-G-A Congenital generalized lipodystrophy type 4 Likely benign (Apr 27, 2017)323256
17-42402899-G-C Congenital generalized lipodystrophy type 4 Likely benign (Apr 27, 2017)323257
17-42402938-A-G Congenital generalized lipodystrophy type 4 Benign (Apr 27, 2017)323258
17-42402983-G-C Congenital generalized lipodystrophy type 4 Benign (Apr 27, 2017)323259
17-42403096-A-C Congenital generalized lipodystrophy type 4 Benign (Apr 27, 2017)323260
17-42403138-G-A Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 13, 2018)891261
17-42403179-C-T Congenital generalized lipodystrophy type 4 Likely benign (Jan 12, 2018)323261
17-42403208-C-T Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 13, 2018)323262
17-42403241-C-G Congenital generalized lipodystrophy type 4 Likely benign (Apr 27, 2017)323263
17-42403374-C-A Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 13, 2018)892452
17-42403455-C-T Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 12, 2018)323264
17-42403473-C-T Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 12, 2018)892453
17-42403486-A-C Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 12, 2018)892454
17-42403502-A-G Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 13, 2018)323265
17-42403577-G-A Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 13, 2018)892455
17-42403688-G-A Congenital generalized lipodystrophy type 4 Uncertain significance (Jan 12, 2018)892456
17-42403689-C-T Congenital generalized lipodystrophy type 4 Benign (Apr 27, 2017)889074
17-42403781-C-T Congenital generalized lipodystrophy type 4 Benign (Apr 27, 2017)323266

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CAVIN1protein_codingprotein_codingENST00000357037 221066
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.004970.8951257300171257470.0000676
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.381952570.7590.00001962482
Missense in Polyphen116153.970.753371540
Synonymous1.081081230.8760.00000997806
Loss of Function1.4059.710.5154.26e-7137

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002060.000206
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.00005450.0000527
Middle Eastern0.00005440.0000544
South Asian0.0001310.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays an important role in caveolae formation and organization. Essential for the formation of caveolae in all tissues (PubMed:18056712, PubMed:18191225, PubMed:19726876). Core component of the CAVIN complex which is essential for recruitment of the complex to the caveolae in presence of calveolin-1 (CAV1). Essential for normal oligomerization of CAV1. Promotes ribosomal transcriptional activity in response to metabolic challenges in the adipocytes and plays an important role in the formation of the ribosomal transcriptional loop. Dissociates transcription complexes paused by DNA-bound TTF1, thereby releasing both RNA polymerase I and pre-RNA from the template (By similarity). {ECO:0000250|UniProtKB:O54724, ECO:0000269|PubMed:18056712, ECO:0000269|PubMed:18191225, ECO:0000269|PubMed:19726876}.;
Disease
DISEASE: Congenital generalized lipodystrophy 4 (CGL4) [MIM:613327]: A disorder characterized by the association of congenital generalized lipodystrophy with muscular dystrophy and cardiac anomalies. Congenital generalized lipodystrophy is characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. {ECO:0000269|PubMed:19726876, ECO:0000269|PubMed:20684003}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Gene expression (Transcription);RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;EGFR1 (Consensus)

Recessive Scores

pRec
0.265

Intolerance Scores

loftool
rvis_EVS
-0.03
rvis_percentile_EVS
51.66

Haploinsufficiency Scores

pHI
0.593
hipred
Y
hipred_score
0.672
ghis
0.622

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Mouse Genome Informatics

Gene name
Cavin1
Phenotype
muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
cavin1a
Affected structure
skeletal muscle cell
Phenotype tag
abnormal
Phenotype quality
convolute

Gene ontology

Biological process
transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;rRNA transcription;positive regulation of cell motility
Cellular component
nucleus;nucleoplasm;cytoplasm;mitochondrion;endoplasmic reticulum;cytosol;plasma membrane;caveola;protein-containing complex;intracellular membrane-bounded organelle;membrane raft
Molecular function
RNA binding;protein binding;rRNA primary transcript binding;identical protein binding